Coherus BioSciences, Inc. (NASDAQ:CHRS) Q1 2023 Earnings Call Transcript May 8, 2023
Coherus BioSciences, Inc. misses on earnings expectations. Reported EPS is $-0.75 EPS, expectations were $-0.57.
Operator: Good day and thank you for standing by. Welcome to the Coherus Biosciences Q1 2023 Earnings Call. Please be advised that today’s conference is being recorded. I would now like to hand the conference over to your first speaker, Marek Ciszewski of Investor Relations for Coherus...
